CMS OKs limited Medicare coverage of costly Alzheimer's test

07/4/2013 | Modern Healthcare (subscription required)

CMS said Medicare will pay for one brain beta-amyloid imaging test per patient as a means to exclude Alzheimer's disease in narrowly defined diagnoses or to aid clinical trials of treatments or prevention strategies. Medicare will not offer widespread coverage of the costly test, used to find brain plaques linked to Alzheimer's disease. An advisory panel had questioned whether the scans would change outcomes for patients with early symptoms of cognitive decline.

View Full Article in:

Modern Healthcare (subscription required)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Cargill
Wayzata, MN
Actuary
Meridian Health Plan
Detroit, MI
Assistant Vice President - Dental Director
MetLife
Bridgewater, NJ
Vice President of Finance
Urban Health Plan, Inc.
Bronx, NY